Search alternatives:
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
significantly a » significantly _ (Expand Search), significantly i (Expand Search), significantly vary (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 201 - 220 results of 18,029 for search '(( significantly a decrease ) OR ( significantly reported decrease ))', query time: 0.61s Refine Results
  1. 201
    Expression of MAGMAS in medulloblastoma.

    Expression of MAGMAS in medulloblastoma. by Zahra Motahari (6814013)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 202
    MAGMAS inhibition on mitochondrial activity in medulloblastoma cells.

    MAGMAS inhibition on mitochondrial activity in medulloblastoma cells. by Zahra Motahari (6814013)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 203
    MAGMAS inhibition induces medulloblastoma cell death.

    MAGMAS inhibition induces medulloblastoma cell death. by Zahra Motahari (6814013)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 204
    BT9 reduces DAOY and D425 medulloblastoma cell invasion.

    BT9 reduces DAOY and D425 medulloblastoma cell invasion. by Zahra Motahari (6814013)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 205
    The effect of MAGMAS inhibition on mitochondrial respiration and acidification rate in D425 cells.

    The effect of MAGMAS inhibition on mitochondrial respiration and acidification rate in D425 cells. by Zahra Motahari (6814013)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 206
    MAGMAS inhibition reduces DAOY cells migration.

    MAGMAS inhibition reduces DAOY cells migration. by Zahra Motahari (6814013)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 207
    BT9 did not improve survival in the orthotopic xenograft model of D425 medulloblastoma.

    BT9 did not improve survival in the orthotopic xenograft model of D425 medulloblastoma. by Zahra Motahari (6814013)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 208
    Grade system.

    Grade system. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 209
    Literature search.

    Literature search. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 210
    Study characteristics.

    Study characteristics. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 211
    Flowchart of literature retrieval.

    Flowchart of literature retrieval. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 212
    Data extraction.

    Data extraction. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 213
    Cochrane Collaboration’s risk of bias tool.

    Cochrane Collaboration’s risk of bias tool. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 214
    General procedure for the synthesis of B.

    General procedure for the synthesis of B. by Xueqin lu (22250795)

    Published 2025
    Save to List
    Saved in:
  15. 215
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  16. 216
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  17. 217
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  18. 218
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  19. 219
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  20. 220
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:

Search Tools: